Promising Results for Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Pancreatic Cancer

June 14, 2017

Tanios Bekaii-Saab, MD, professor of Medicine, Mayo Clinic, discusses results of the CanStem111P trial, a phase III study of napabucasin plus nab-paclitaxel with gemcitabine in adult patients with metastatic pancreatic adenocarcinoma.